Funding for this research was provided by:
AstraZeneca Austria
Medical University of Vienna
Article History
Accepted: 17 November 2020
First Online: 3 December 2020
Declarations
:
: Open access funding provided by Medical University of Vienna. The study was funded by AstraZeneca Austria.
: Anna Buder has received honoraria from AstraZeneca. Maximilian J. Hochmair has received honoraria from AstraZeneca, Bristol-Myers Squibb, Boehringer Ingelheim, Merck Sharp & Dohme, Pfizer, and Roche and had consulting or advisory roles with Boehringer Ingelheim, Merck Sharp & Dohme, Novartis, and Roche. Martin Filipits has received honoraria for advisory boards from Astra Zeneca, Bayer, Biomedica, Biorad, Boehringer Ingelheim, Myriad Genetics Inc., Pfizer, and Roche.
: Sample collection and analysis was performed in accordance with the local ethics committee (EK No. 1132/2016). All patients gave their written informed consent for providing blood specimens for plasma genotyping.
: All authors agreed to participate.
: All authors have approved the final version submitted.
: Not applicable.
: Not applicable.
: All authors made substantial contributions to the conception and design of the study, acquisition of data, analysis and interpretation of data, drafting the article, and revising it critically for important intellectual content.